Doersam, Bastian; Seiwert, Nina; Foersch, Sebastian et al.
PARP-1 protects against colorectal tumor induction, but promotes inflammation-driven colorectal tumor progressionPROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. Bd. 115. H. 17. 2018 S. E4061-E4070
Cook, N. S.; Balp, M.; Chatterjee, S. et al.
PATIENTS WITH NON-ALCOHOLIC STEATOHEPATITIS (NASH) REPORT POSITIVE EXPERIENCE AFTER PARTICIPATING IN AN ONLINE QUANTITATIVE PREFERENCE SURVEYVALUE IN HEALTH. Bd. 21. 2018 S. S148-S149
Kraemer, Judith; Triantafyllias, Konstantinos; Kohnen, Wolfgang et al.
Patients with Rheumatic Diseases do not have an Increased Risk of MRSA Carrier StatusRHEUMATOLOGY AND THERAPY. Bd. 5. H. 2. 2018 S. 371-381
Moehler, M.; Maderer, A.; Lordick, F. et al.
Perioperative chemotherapy plus /- EGFR inhibition in unselected patients with locally advanced esophagogastric cancer: a randomized phase II study with a large advanced biomarker program of the German Cancer Society (AIO/CAO STO-0801)ONCOLOGY RESEARCH AND TREATMENT. Bd. 41. 2018 S. 69-69
Huber, Y.; Pfirrmann, D.; Gebhardt, I. et al.
Persistent improvement of liver function tests and health-related quality of life from an individualized exercise program in patients with histological confirmed NAFLD - the HELP studyJOURNAL OF HEPATOLOGY. Bd. 68. 2018 S. S580-S580
Zimmermann, Anca; Zwerenz, Ruediger; Droste, Michael et al.
Personality Traits and Physical Complaints in Patients With Acromegaly: A Cross Sectional Multi-Center Study With Analysis of Influencing FactorsFRONTIERS IN ENDOCRINOLOGY. Bd. 9. 2018
Bang, Y. -J.; Ruiz, E. Yanez; Van Cutsem, E. et al.
Phase III, randomised trial of avelumab versus physician's choice of chemotherapy as third-line treatment of patients with advanced gastric or gastro-oesophageal junction cancer: primary analysis of JAVELIN Gastric 300ANNALS OF ONCOLOGY. Bd. 29. H. 10. 2018 S. 2052-2060
Vogel, Arndt; Kasper, Stefan; Bitzer, Michael et al.
PICCA study: panitumumab in combination with cisplatin/gemcitabine chemotherapy in KRAS wild-type patients with biliary cancer-a randomised biomarker-driven clinical phase II AIO studyEUROPEAN JOURNAL OF CANCER. Bd. 92. 2018 S. 11-19
Kahaly, G. J.; Frommer, L.
Polyglandular autoimmune syndromesJOURNAL OF ENDOCRINOLOGICAL INVESTIGATION. Bd. 41. H. 1. 2018 S. 91-98
Kloeckner, R.; Maehringer-Kunz, A.; Dos Santos, D. P. et al.
Portal vein tumor thrombosis has a direct impact on liver functionJOURNAL OF HEPATOLOGY. Bd. 68. 2018 S. S209-S209